Genmab A/S (GMAB)
NASDAQ: GMAB · Real-Time Price · USD
22.21
+0.40 (1.83%)
At close: Jun 6, 2025, 4:00 PM
22.20
-0.01 (-0.05%)
After-hours: Jun 6, 2025, 4:04 PM EDT

Genmab Stock Forecast

Stock Price Forecast

According to 6 professional analysts, the 12-month price target for Genmab stock ranges from a low of $27 to a high of $48. The average analyst price target of $39.17 forecasts a 76.36% increase in the stock price over the next year.

Price Target: $39.17 (+76.36%)
Analyst Consensus: Buy
Target Low Average Median High
Price $27 $39.17 $45 $48
Change +21.57% +76.36% +102.61% +116.12%
* Price targets were last updated on Apr 9, 2025.

Analyst Ratings

The average analyst rating for Genmab stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Jan '25Feb '25Mar '25Apr '25May '25Jun '25
Strong Buy 333333
Buy 234444
Hold 222222
Sell 111000
Strong Sell 000000
Total 8910999

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$50$37
Strong Buy Reiterates $50$37 +66.59% Apr 9, 2025
Truist Securities
Truist Securities
Strong Buy
Maintains
$50$45
Strong Buy Maintains $50$45 +102.61% Mar 11, 2025
William Blair
William Blair
Buy
Upgrades
n/a
Buy Upgrades n/a n/a Mar 11, 2025
Leerink Partners
Leerink Partners
Buy
Upgrades
$27
Buy Upgrades $27 +21.57% Feb 13, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$50
Strong Buy Reiterates $50 +125.12% Jan 23, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
25.33B
from 2.99B
Increased by 747.74%
Revenue Next Year
29.09B
from 25.33B
Increased by 14.81%
EPS This Year
106.15
from 16.85
Increased by 530.06%
EPS Next Year
127.16
from 106.15
Increased by 19.79%
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
1.66B1.29B2.08B2.44B2.99B25.33B29.09B33.10B
Revenue Growth
106.20%-22.52%61.88%17.23%22.32%747.74%14.81%13.80%
EPS
11.876.8511.879.7916.85106.15127.16156.10
EPS Growth
132.20%-42.30%73.29%-17.49%72.08%530.06%19.79%22.76%
Forward PE
-----0.210.170.14
No. Analysts
-----272618
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20252026202720282029
High 27.2B 32.3B 37.9B
Avg 25.3B 29.1B 33.1B
Low 22.6B 26.0B 28.2B

Revenue Growth

Revenue Growth 20252026202720282029
High
808.5%
27.5%
30.4%
Avg
747.7%
14.8%
13.8%
Low
655.0%
2.6%
-3.2%

EPS Forecast

EPS 20252026202720282029
High 139.40 154.12 194.49
Avg 106.15 127.16 156.10
Low 81.78 94.71 114.90

EPS Growth

EPS Growth 20252026202720282029
High
727.4%
45.2%
52.9%
Avg
530.1%
19.8%
22.8%
Low
385.4%
-10.8%
-9.6%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.